Last reviewed · How we verify
ZKY001 EYE DROPS
At a glance
| Generic name | ZKY001 EYE DROPS |
|---|---|
| Also known as | Germinal peptide eye drops |
| Sponsor | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect (PHASE1)
- To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis (PHASE2)
- A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops (PHASE2)
- ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial (PHASE2)
- Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |